209 related articles for article (PubMed ID: 9892384)
21. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
Litwin M; Boguszewska-Baczkowska A; Jelonek A
Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
[TBL] [Abstract][Full Text] [Related]
22. Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients.
Duff DR; Golper TA; Sloan RS; Brier ME; Aronoff GR
Am J Kidney Dis; 1991 Jul; 18(1):60-4. PubMed ID: 2063856
[TBL] [Abstract][Full Text] [Related]
23. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
24. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
25. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness.
Eschbach JW
J Am Soc Nephrol; 2002 May; 13(5):1412-4. PubMed ID: 11961032
[No Abstract] [Full Text] [Related]
26. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
[TBL] [Abstract][Full Text] [Related]
27. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
[TBL] [Abstract][Full Text] [Related]
28. [Results of using human recombinant erythropoietin in a patient treated by peritoneal dialysis complicated by chronic infection of the tunnel of the dialysis catheter].
Wanic-Kossowska M; Grzegorzewska A; Piszczek I; Krzymański M
Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):694-5. PubMed ID: 1492040
[No Abstract] [Full Text] [Related]
29. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
30. Intensity of hemodialysis and response to erythropoietin.
Uréna P; Pétrover M
N Engl J Med; 1996 Jun; 334(25):1669; author reply 1670-1. PubMed ID: 8628368
[No Abstract] [Full Text] [Related]
31. Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients.
Charytan C; Goldfarb-Rumyantzev A; Wang YF; Schwenk MH; Spinowitz BS
Am J Nephrol; 1998; 18(6):498-503. PubMed ID: 9845824
[TBL] [Abstract][Full Text] [Related]
32. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
33. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients.
Beusterien KM; Nissenson AR; Port FK; Kelly M; Steinwald B; Ware JE
J Am Soc Nephrol; 1996 May; 7(5):763-73. PubMed ID: 8738812
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human erythropoietin: implications for nephrology.
Eschbach JW; Adamson JW
Am J Kidney Dis; 1988 Mar; 11(3):203-9. PubMed ID: 3278599
[TBL] [Abstract][Full Text] [Related]
35. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
Korbet SM
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
[TBL] [Abstract][Full Text] [Related]
36. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin for anemia of renal failure in sickle cell disease.
Steinberg MH
N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
[No Abstract] [Full Text] [Related]
38. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
Mohini R
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
[TBL] [Abstract][Full Text] [Related]
39. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA
Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
